Heterogeneity testing and hypothesis testing
Subgroups |
Heterogeneity |
Heterogeneity |
Heterogeneity |
Point estimate (Fixed) |
95%
CI |
95% CI |
Point estimate (Random) |
95%
CI |
95% CI |
Fixed effects model |
Fixed
effects model |
Fixed effects model |
Random effects
studies |
Random effects studies |
Random effects
studies |
|
Q |
P |
I² |
|
Low |
High |
|
Low |
High |
Z |
P |
Studies |
Z |
P |
Studies |
Symptomatic COVID-19 |
3.989 |
0.136 |
49.891 |
1.3666 |
1.197 |
1.558 |
1.389 |
1.135 |
1.701 |
4.625 |
0 |
3 |
3.184 |
0.001 |
3 |
COVID-19 progression |
2.764 |
0.251 |
27.649 |
1.502 |
0.841 |
2.682 |
1.313 |
0.6 |
2.877 |
1.375 |
0.169 |
3 |
0.682 |
0.495 |
3 |
COVID-19 Hospitalization |
0.417 |
0.519 |
0 |
1.79 |
1.76 |
1.82 |
1.79 |
1.76 |
1.82 |
68.653 |
0 |
2 |
68.653 |
0 |
2 |
ICU admissions |
7.405 |
0.192 |
32.477 |
1.395 |
1.221 |
1.594 |
1.318 |
1.086 |
1.6 |
4.895 |
0 |
6 |
2.791 |
0.005 |
6 |
IMV requirements |
4.347 |
0.114 |
53.989 |
1.869 |
1.354 |
2.578 |
1.466 |
0.753 |
2.853 |
3.804 |
0 |
3 |
1.125 |
0.26 |
3 |
COVID-19 Mortality |
12.542 |
0.324 |
12.295 |
0.923 |
0.82 |
1.038 |
0.908 |
0.795 |
1.037 |
-1.335 |
0.182 |
12 |
-1.422 |
0.155 |
12 |
COVID-19 Severity |
19.906 |
0.098 |
34.692 |
1.3 |
1.181 |
1.432 |
1.261 |
1.09 |
1.46 |
5.339 |
0 |
14 |
3.109 |
0.002 |
14 |